NCT02094664

Brief Summary

The purpose of this study is to compare heat and humidified oxygen with cold and dry oxygen in children with bronchiolitis. The hypotheses are that heating and humidifying inspired low flow supplemental oxygen will optimize mucociliary function thereby, 1) improve oxygenation, 2) decrease work of breathing, and 3) decrease length of hospital stay.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2014

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 18, 2014

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 24, 2014

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2015

Completed
2.6 years until next milestone

Results Posted

Study results publicly available

January 8, 2018

Completed
Last Updated

January 8, 2018

Status Verified

January 1, 2018

Enrollment Period

1.4 years

First QC Date

March 18, 2014

Results QC Date

July 30, 2017

Last Update Submit

January 5, 2018

Conditions

Keywords

HeatHumidificationOxygen

Outcome Measures

Primary Outcomes (2)

  • Change in Respiratory Distress Assessment Instrument (RDAI) From Baseline.

    The RDAI is a validated clinical scoring system to assess respiratory distress and has been used in several bronchiolitis studies. The RDAI is based on two variables, wheezing and retractions, in which points are applied to each to give a score ranging from 0 to 17. The higher the total score, the worse the subject was clinically. Reported are the absolute scores at each time point, for each arm. Baseline scores are reported in the Baseline Module.

    Baseline, Hour 1, Hour 4, Hour 8, and Hour 12

  • Change in Respiratory Rate (RR) From Baseline

    Respiratory rate was measured by counting respirations for one minute. Reported are the absolute scores at each time point, for each arm. Baseline scores are reported in the Baseline Module.

    Baseline, Hour 1, Hour 4, Hour 8, and Hour 12

Secondary Outcomes (2)

  • Length of Hospital Stay

    Subjects will be followed for the duration of hospital stay until discharge

  • Duration of O2 Use

    Subjects will be followed for the duration of oxygen requirement until oxygen discontinued

Study Arms (2)

Standard oxygen via nasal cannula

NO INTERVENTION

Standard therapy

Heated and humidified oxygen

ACTIVE COMPARATOR

Heated and humified oxygen

Device: Heated and humidified oxygen

Interventions

Heated and humidified oxygen

Eligibility Criteria

AgeUp to 24 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Ages ≤24 months of age
  • Physician diagnosed bronchiolitis
  • Admitted to pediatric floor
  • Supplemental oxygen requirement, \<4 L/min, for hypoxemia, oxygen saturation \<92% in room air

You may not qualify if:

  • Prematurity, born \<37 weeks gestational age
  • Admitted to pediatric intensive care unit for medical indication
  • Requirement of heated, humidified high flow system
  • Chronic lung disease (such as bronchopulmonary dysplasia, cystic fibrosis, primary ciliary dyskinesia, tracheostomy status, baseline oxygen requirement)
  • Neuromuscular disorders
  • Chromosomal defects
  • Metabolic disorders
  • Immunodeficiency
  • Unrepaired cardiac abnormalities

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Hospital and Research Center Oakland

Oakland, California, 94609, United States

Location

MeSH Terms

Conditions

BronchiolitisHypoxia

Condition Hierarchy (Ancestors)

BronchitisRespiratory Tract InfectionsInfectionsBronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Dr. Diana Chen
Organization
UCLA Mattel Children's Hospital

Study Officials

  • Diana Chen, M.D.

    UCSF Benioff Children's Hospital Oakland

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Pediatric Pulmonary Fellow

Study Record Dates

First Submitted

March 18, 2014

First Posted

March 24, 2014

Study Start

January 1, 2014

Primary Completion

June 1, 2015

Study Completion

June 1, 2015

Last Updated

January 8, 2018

Results First Posted

January 8, 2018

Record last verified: 2018-01

Locations